These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 1594278

  • 21. Efficacy and Safety of Ropivacaine Addition to Intrathecal Morphine for Pain Management in Intractable Cancer.
    Huang Y, Li X, Zhu T, Lin J, Tao G.
    Mediators Inflamm; 2015; 2015():439014. PubMed ID: 26556955
    [Abstract] [Full Text] [Related]

  • 22. Tolerance during long-term administration of intrathecal morphine.
    Ali NM, Hoffman JS.
    Conn Med; 1989 May; 53(5):266-8. PubMed ID: 2736913
    [Abstract] [Full Text] [Related]

  • 23. Constant infusion of morphine for intractable cancer pain using an implanted pump.
    Hassenbusch SJ, Pillay PK, Magdinec M, Currie K, Bay JW, Covington EC, Tomaszewski MZ.
    J Neurosurg; 1990 Sep; 73(3):405-9. PubMed ID: 2384779
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Neurohistopathological findings after continuous intrathecal administration of morphine or a morphine/bupivacaine mixture in cancer pain patients.
    Wagemans MF, van der Valk P, Spoelder EM, Zuurmond WW, de Lange JJ.
    Acta Anaesthesiol Scand; 1997 Sep; 41(8):1033-8. PubMed ID: 9311403
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Retrospective investigation of intermittent bolus intrathecal morphine for cancer pain patients.
    Cheng KI, Tang CS, Chu KS, Yip NS, Yu KL, Tseng CK.
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1993 Nov; 9(11):632-42. PubMed ID: 8046782
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Comparison of intermittent bolus with continuous infusion of epidural morphine in the treatment of severe cancer pain.
    Gourlay GK, Plummer JL, Cherry DA, Onley MM, Parish KA, Wood MM, Cousins MJ.
    Pain; 1991 Nov; 47(2):135-140. PubMed ID: 1762806
    [Abstract] [Full Text] [Related]

  • 34. [Treatment of severe cancer pain via spinal catheters].
    Andersen JS, Markers PI, Valentin N.
    Ugeskr Laeger; 1996 Nov 11; 158(46):6613-6. PubMed ID: 8966828
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Loss of intrathecal morphine analgesia in terminal cancer patients is associated with high levels of excitatory amino acids in the CSF.
    Wong CS, Chang YC, Yeh CC, Huang GS, Cherng CH.
    Can J Anaesth; 2002 Nov 11; 49(6):561-5. PubMed ID: 12067866
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Intrathecal therapy for cancer and non-cancer pain.
    Hayek SM, Deer TR, Pope JE, Panchal SJ, Patel VB.
    Pain Physician; 2011 Nov 11; 14(3):219-48. PubMed ID: 21587327
    [Abstract] [Full Text] [Related]

  • 39. Continuous intraventricular morphine- or peptide-infusion for intractable cancer pain.
    Weigl K, Mundinger F, Chrubasik J.
    Acta Neurochir Suppl (Wien); 1987 Nov 11; 39():163-5. PubMed ID: 3478979
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.